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The aim of this study is to investigate the effect of acute acetaminophen (ACT) ingestion on eight 
maximal 30-second cycling bouts, interspersed with two-minute rests. Seven recreationally active females 
(N=7, 22.8±6.7 years of age, with a stature of 163.4±5.8 cm, and body mass of 58.9±5.9 kg) participated in 
a placebo-controlled, randomized crossover design. Pain perception, heart rate, and power profiles were 
analyzed using a time x condition repeated measures ANOVA. Blood lactate after the eighth bout and total 
work done were analyzed using the paired samples t-test. Participants achieved a significantly greater (p=.007, 
=.725) peak power output during the ACT trials (402.9±73.8 W, 95% CI=334.6–471.1 W) when compared to 
the placebo (PLA) trials (378.7±64.6 W, 95% CI=319.0–438.4 W). Supplementation of ACT had no effect on 
mean power output, blood lactate accumulation, pain perception, or total work done after eigth bouts (p>.05). 
Data presented here suggest females can improve peak power output during repeated Wingate tests with ACT 
ingestion. It is proposed that the altered afferent feedback may have caused these alterations in power output.
Key words: acetaminophen, pain, perception, power output, Wingate test
Introduction
The capacity to repeat high-intensity efforts 
is crucial to performance in a variety of sports, 
including team and racket sports (Fernandez-Fer-
nandez, Zimek, Wiewelhove, & Ferrauti, 2012; 
Mendez-Villanueva, Hamer, & Bishop, 2007). 
Several types of training have been proven ben-
eicial for performance in these sports, including 
repeated sprint training (sprint ≤10 seconds, sepa-
rated by recovery periods ≤60 seconds), intermit-
tent sprint training (sprint ≤10 seconds, separated 
by recovery periods ≥60 seconds), or sprint interval 
training (sprint ≥30 seconds, separated by recov-
ery periods ≥60 seconds), (Bishop, Girard, & Men-
dez-Villanueva, 2011; Buchheit & Laursen, 2013). 
Investigations concerning determinants of sprint 
interval training (SIT) performance have revealed 
that fatigue taking place between the initial and 
inal sprints is multifactorial, and may be induced 
by various peripheral and central factors (Buch-
heit & Laursen, 2013). While peripheral factors, 
including muscle excitability, metabolite accumula-
tion, and ionic disturbances have been extensively 
studied (Mohr, et al., 2004; Sahlin & Ren, 1989), 
less research has focused on the potential role of 
central fatigue (Foster, Taylor, Chrismas, Watkins, 
& Mauger, 2014). A recent study suggested that SIT 
performance may be limited by neural drive and the 
central regulation of motor unit recruitment (Ross, 
Gregson, Williams, Roberston, & George, 2010).
Recently, interrelationships between central and 
peripheral factors of fatigue during SIT have been 
investigated (Amann, Sidhu, Weavil, Mangum, 
& Venturelli, 2015; Stone, et al., 2012; Swart, et 
al., 2009). Tucker (2009) proposed an association 
between the development of peripheral fatigue and 
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central motor drive through alterations in afferent 
neural feedback from the myoibrils to the central 
nervous system (CNS). These changes may be 
related to nociceptive feedback following exer-
cise-induced pain. Indeed, various metabolites (e.g. 
hydrogen and potassium ions) released during high-
intensity exercise increase nociceptive signals to the 
central nervous system (CNS) through the stimula-
tion of type III and type IV afferent muscle ibres, 
which in turn could regulate the central regula-
tion of motor unit recruitment (Amann, Proctor, 
Sebranek, Pegelow, & Dempsey, 2009).
Since exercise-induced pain is a limiting factor 
of performance during high-intensity activities 
(Foster, et al., 2014), the consumption of analgesic 
substances, such as aspirin, caffeine or ampheta-
mines has become common practice among athletes 
(Tscholl, Alonso, Dolle, Junge, & Dvorak, 2010). 
However, it is dificult to dissociate the analge-
sic effects of these drugs from their other actions, 
including anti-inlammatory, metabolic or psycho-
logical. In contrast, acetaminophen (ACT) is a non-
steroidal non-opioid analgesic available over-the-
counter associated with limited effects other than 
pain inhibition. The analgesic properties of ACT 
rely on various mechanisms, including the inhibi-
tion of the enzyme cyclooxygenase (responsible for 
the synthesis of prostaglandins), and a modulation 
of afferent and efferent pain pathway (Andersson, 
et al., 2011).
Research concerning the role of ACT on exer-
cise performance is limited to its antipyretic prop-
erties, with signiicant improvements in the time to 
exhaustion during running performed in the heat 
following acute ingestion (Burtscher, et al., 2013). 
To our knowledge, only two experimental trials has 
focused on the analgesic effects of ACT on exercise 
performance in thermoneutral conditions (Foster, 
et al., 2014; Mauger, Jones, & Williams, 2010). 
Mauger and colleagues (2010) reported improved 
self-paced 10-mile (16.1 km) time trial performance 
in trained male cyclists (26 minutes 15 seconds vs. 
26 minutes 45 seconds for ACT and placebo con-
ditions respectively). Foster et al. (2014) reported 
that, compared to a placebo, ingestion of 1.5 g ACT 
prior to eight bouts of 30 s Wingate Anaerobic Tests 
(WAnTs) signiicantly increased mean power output 
in the inal three sprints, resulting in a signiicantly 
greater overall mean power output and a lower per-
centage power decrement. Changes were accompa-
nied by the unaltered pain perception, peak power 
output, and heart rate between ACT and placebo 
(PLA) conditions.
It is well established that men and women have 
dissimilar pain responses, with women character-
ized by a lower pain tolerance (Naugle, Naugle, Fill-
ingim, & Riley, 2014; Tashani, Alabas, & Johnson, 
2010). Gender differences are attributable to hor-
monal responses, blood pressure and body size 
(Tashani, et al., 2010). As a result, analgesic efi-
cacy of ACT may be altered in females compared 
to males. Moreover, a lack of female participants in 
sports medicine research has recently been reported 
(Costello, Bieuzen, & Bleakley, 2014) and therefore, 
the aim of the present investigation was to inves-
tigate the inluence of ACT on RSE in females. It 
was hypothesized ACT would improve power pro-
iles during eight 30-second WAnTs.
Methods
Participants
Seven females (22.8±6.7 years of age, with a 
stature of 163.4±5.8 cm, and body mass of 58.9±5.9 
kg) participated in the present investigation. Par-
ticipants were recreationally active (they exercised 
for an average of 6.1±3.1 h·wk-1), but were not well 
trained. Participants abstained from alcohol, caf-
feine and exercise for 24 hours prior to the inves-
tigation. Participants arrived at the laboratory in a 
4 hour fasted condition as requested according to 
self-reporting. To increase reliability, participants 
were allocated the same appointment time on all 
visits to the laboratory to attenuate diurnal varia-
tions (Hayes, Bickerstaff, & Baker, 2010). Preced-
ing the data collection and exercise, participants 
completed a Physical Activity Readiness Question-
naire (PAR-Q) and gave their full written consent 
to participation. The study was approved by the 
London Metropolitan University Ethics Committee.
Experimental design
After an initial familiarization session to get 
accustomed to measurement tools, participants 
reported to the laboratory on two separate occa-
sions separated by a minimum of 48 hours. A pla-
cebo-controlled, randomized crossover design was 
used. Upon arrival at the laboratory, participants 
ingested an orange lavoured drink (300 ml) con-
taining either an additional 1.5 g ACT or nothing 
additional to lavouring (PLA [as used by Foster et 
al. (2014)]). Thirty minutes were allowed between 
ingestion and commencement of exercise to allow 
for peak plasma ACT levels to occur (Grosser, 
Smyth, & Fitzgerald, 2011). Participants completed 
a standardized three minute warm-up involving 
pedalling at 60 rpm interspersed with three 2-3-
second all-out sprints on a stationary cycle ergom-
eter (Monark 874, Monark, Sweden). A recov-
ery period of ive minutes was allowed between 
the warm-up and the test. Participants completed 
eight WAnTs against a load corresponding to 5% 
body mass applied to the lywheel, each separated 
by two minutes of active recovery. This schedule 
was chosen to cause increased pain due to limited 
metabolite clearance (Sinoway, Hill, Pickar, & 
Kaufman, 1993) and has been previously used in 
male participants (Foster, et al., 2014). Power output 
Delextrat, A. et al.: ACETAMINOPHEN INGESTION IMPROVES REPEATED SPRINT... Kinesiology 47(2015)2:145-150
147
was calculated per second for the duration of each 
WAnT and peak power output, mean power output 
(both in W), and total work done (kJ) were calcu-
lated using WAnT software test package for Monark 
874 (version 2.2). Heart rate (b·min-1) was recorded 
during the last 1-2 seconds of each WAnT. After 20 
seconds of each sprint, participants selected a score 
on a ten-point scale accompanied by verbal descrip-
tions to assess perceived pain between conditions 
(Cook, O’Connor, Eubanks, Smith, & Lee, 1997). 
This was chosen since high intra-class correlations 
(r=0.88-0.98) suggest this scale is a reliable measure 
of pain intensity during exercise. 
 Participants were verbally encouraged through-
out the test to avoid pacing and to sustain their 
supramaximal effort throughout the test. Post 
exercise blood lactate (mmol·L-1) was measured 
two minutes following the completion of the inal 
WAnT (Lactate Pro, Arkray, Inc., Kyoto, Japan), 
in accordance with previous studies (e.g. Robach, 
et al., 1997).
Statistical analysis
Data were analyzed using SPSS version 21 
(IBM North America, New York, NY, USA). Con-
ventional methods, mean and standard deviations 
(SD) were used to analyze descriptive data. Data 
were tested for normal distribution by Shapiro-
Wilk’s test and for homogeneity of variance using 
Levene’s test. Following conirmation of parame-
tricity, a two-way analysis of variance (ANOVA 
[condition × bout]) with repeated measures was 
used to test for differences in mean power output, 
peak power output, pain and HR. Where a main 
effect was observed, a Sidak post-hoc test was used 
to locate signiicant differences. Differences in total 
work done and post exercise blood lactate were ana-
lysed using a paired t-test. Also, 95% conidence 
intervals (CI) and effect size (ES) are presented. 
Signiicance was set a priori at p<.05 and observed 
power was .909 for peak power output.
Results
No signiicant effect of condition (ACT vs. PLA) 
existed for mean power output (p=.103; =.380); 
however a moderate effect was observed. ANOVA 
revealed a signiicant, large, main effect for bout 
number on mean power output (p<.001, =.938). 
Post-hoc analysis revealed mean power output 
during bout one was signiicantly greater than 
subsequent bouts (p<.05). Participants achieved a 
signiicantly greater (p=.007, =.725) peak power 
output during the ACT trials (402.9±73.8 W, 95% 
CI=334.6-471.1 W) when compared to the PLA 
trials (378.7±64.6 W, 95% CI=319.0-438.4 W), asso-
ciated with a large effect size. ANOVA revealed a 
main, large, effect of bout number on peak power 
output (p<.001, =.871). Post-hoc analysis revealed 
peak power outputs during bouts 4-8 were signii-
cantly lower than during bout one (p<.05). Heart 
rate was not signiicantly different between condi-
tions or bouts (respectively for ACT and placebo: 
172±9 vs. 161±26, 174±10 vs. 166±22, 175±9 vs. 
174±13, 173±9 vs. 173±14, 174±9 vs. 171±14, 172±10 
Figure 1. Power output profiles during eight 30-second Wingate anaerobic tests following consumption of acetaminophen (ACT) and 
placebo (PLA). ACT resulted in a greater peak power output than PLA (p<.05). Mean power output was not significantly different 
between groups (p>.05). *Significantly different between conditions for an individual bout. Data are presented as M±SEM for clarity.
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vs. 173±13, 173±9 vs. 172±15, and 176±10 vs. 174±14, 
for bouts one to eight, p>.05). Pain perception dis-
played no main effect for condition, but bouts six 
to eight elicited a signiicantly greater perception 
of pain than bouts one to two (p<.05). Supplemen-
tation of ACT had no effect on blood lactate accu-
mulation (14.3±1.7 vs. 14.3±1.2 mmol∙L-1, respec-
tively for ACT and PLA conditions) or total work 
done (58.5±8.0 vs. 56.8±8.1 J, respectively for ACT 
and PLA conditions) after the eight bouts (p>.05).
Discussion and conclusions
For the irst time, we report the eficacy of 
1.5 g ACT ingestion to enhance SIT performance 
in females. Peak power output was signiicantly 
improved over eight WAnTs with the ingestion of 
ACT. However, no signiicant changes in mean 
power output, pain perception or physiological 
parameters (heart rate, blood lactate) were found 
between ACT and PLA conditions.
Our results differ from those concerning recre-
ationally active males where no difference in peak 
power output was reported, whilst a bout x condition 
interaction for mean power output was observed, 
indicating only the inal three bouts of eight WAnTs 
improved with ACT supplementation (Foster, et al., 
2014). These discrepancies suggest that the analge-
sic effect of ACT ingestion may allow females to 
perform closer to their physiological maximum from 
the start of the SIT, while the effect of ACT in men 
starts later because these latter have a higher pain 
threshold (Tashani, et al., 2010). However, it may be 
suggested these data relect gender differences in 
fatigue resistance (Hunter, 2014). As fatigue resist-
ance is greater in women than men, it is not entirely 
surprising that ACT improves fatigue resistance in 
men but not in women. Interestingly, the variation 
in mechanical power between ACT and PLA condi-
tions occurred without any change in physiological 
parameters, which is in agreement with the ind-
ings from Foster and colleagues (2014). As stated 
by these authors, a limitation of their study was the 
absence of blood lactate measurement. Within this 
context, the present study included post-exercise 
blood lactate sampling, showing high values but 
not signiicantly different between the conditions 
(14.3±1.7 vs. 14.3±1.2 mmol∙L-1, respectively for 
ACT and PLA conditions). Hydrogen ions (linked 
to lactate) are amongst the metabolites known to 
increase nociceptive signals to the CNS through the 
stimulation of type III and type IV afferent muscle 
ibres. Consequently, we can hypothesize that for 
similar concentrations of lactate (and thus of hydro-
gen ions), ACT may have played a role in the nocic-
eptive signal and decreased inhibition of the central 
motor drive usually observed with pain (Amann, et 
al., 2009), thus allowing an increase in peak power 
output. Interestingly, Mauger and colleagues (2010) 
previously reported altered blood lactate concentra-
tions and heart rate responses to ACT when com-
pared to PLA. However, this was during a 10-mile 
cycling time trial rather than RSE, which highlights 
the speciicity of RSE exercise.
Differences in metabolic pathway contributions 
may explicate the discrepancy between cardiorespi-
ratory parameters in the present investigation and 
those of Mauger and colleagues (2010) – the partici-
pants in the latter were exercising for approximately 
26 minutes and would therefore rely on glycolytic 
and oxidative metabolism; whereas in the present 
investigation, participants were primary metaboliz-
ing intramuscular stores initially. However, consid-
ering the interval length (30 s), constrained recov-
ery (two minutes) and repeated bouts it is likely that 
the work bouts were primarily reliant on oxidative 
metabolism. When two 30-second sprints were sep-
arated by four minutes of recovery, there was a 25% 
reduction in work performed in the second sprint, 
and an increase in oxidative metabolism such as this 
pathway met up to 43% of the energy demand (Bog-
danis, Nevil, Boobis, & Lakomy, 1996). Consider-
ing the present investigation employed less recovery 
and more sprints, it is likely that a large portion of 
energy demand was met by oxidative metabolism. 
Regardless of the exact mechanism, the indings of 
the present investigation add to the increasing body 
of evidence (Amann & Dempsey, 2008; Noakes, 
2012), suggesting that human muscle fatigue does 
not reside solely in the muscle (Ganevia, 2001) and 
that the CNS regulates both the prolonged (Noakes, 
2011; Stone, et al., 2012; Swart, et al., 2009), inter-
mittent (Foster, et al., 2014) and, in the case of the 
present investigation, short duration (as peak power 
output is typically reached ~5 seconds, [Herbert, 
Sculthorpe, Baker, & Grace, 2015]) exercise per-
formance. It is worthwhile noting however that our 
investigation concerned females, and therefore rep-
lication in males may not result in the same perfor-
mance enhancement. 
Several factors may explain the gender-speciic 
responses to ACT during RSE. It is well-known that 
females have a greater sensitivity to pain and a lower 
pain threshold than males (Hunter, 2014; Tashani, 
et al., 2010). Within this context, the lower pain 
threshold of our participants could partly explain 
the quicker effects of ACT on power output com-
pared to males, with the differences between ACT 
and PLA conditions observed in peak power output 
from the start of RSE in our study, whereas delayed 
effects of ACT were reported in males (Foster, et 
al., 2014).
The main physiological parameters that could 
explain the gender differences in pain threshold, 
and thus the contrasting effects of ACT, include 
body size and blood pressure. It is interesting to note 
that effects of ACT observed in the present study 
were different from the study of Foster et al. (2014), 
and besides the gender differences, our participants 
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were considerably lighter (59±6 kg compared to 
75±14 kg). Therefore, although our 1.5 g dosage was 
the same as in Foster et al. (2014), the relative dose 
was greater, which could explain the greater effects 
of ACT observed in the present study. However, it 
should be noted that positive effects of ACT on pain 
perception and performance have not always been 
reported, and very large doses should be avoided. 
Indeed, despite an abundance of evidence suggest-
ing that depression of pain perception or peripheral 
feedback enhances performance (Foster, et al., 2014; 
Mauger, et al., 2010; Stone, et al. 2012), Amann and 
colleagues (2009) reported that complete blocking 
of lower limb afferent feedback actually reduced 
performance due to an overly aggressive start to 
a time trial and therefore a depletion of the cur-
vature constant parameter (W’), (Skiba, Chidnok, 
Vanhatalo, & Jones, 2012).
The main limitation of the present study was 
a relatively small sample size (N=7). However we 
mostly reported moderate to large effect sizes, 
which suggests that our results can be applied to 
larger populations.
In conclusion, the present study showed bene-
its of ACT ingestion on RSE capacity in females, 
with an improvement of peak power output gen-
erated during each sprint, with no signiicant dif-
ference in mean power output, heart rate, blood 
lactate, or pain perception observed between the 
conditions. Although we do not endorse chronic 
supplementation of ACT, acute doses prior to com-
petition may enhance performance. This informa-
tion has applications for sprint coaches and ath-
letes alike. However, it is important to acknowl-
edge that the current work was performed in rec-
reational and not highly trained females.  Therefore, 
those working with highly trained females should 
treat these indings with caution. Future research 
may wish to concern whole body exercise to deter-
mine whether a greater magnitude of inluence is 
exerted by ACT.
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